Introducing DataLookout: Stop Manually Checking ClinicalTrials.gov

You already know the problem

You open ClinicalTrials.gov. You search for your disease area. You scroll through results and try to spot what's different from last week. Did that Phase 3 start recruiting? Did Pfizer update their endpoint? Is there a new sponsor in your space?

You can't tell, because ClinicalTrials.gov is a database. It shows you the current state. It doesn't show you what changed.

The real risk isn't wasted time. It's the changes you never see. A competitor opens recruitment in your indication. A Phase 3 trial quietly modifies its primary endpoint. A new sponsor files their first trial in your disease area. By the time you find out at a conference six months later, you've already lost the first-mover advantage.

Enterprise monitoring tools solve this, but they typically require annual contracts starting at tens of thousands of dollars per seat and take weeks to implement. Most biotech teams just live with the manual process. Or they skip it entirely.

What DataLookout does

We check ClinicalTrials.gov every day. When something changes on a trial you care about, we tell you. That's the whole product.

46,689

Trials Monitored

18,111

Recruiting

Disease Areas

Daily

Updates

We detect four types of changes

Status changes like recruitment opening, trials completing, or studies getting suspended
Protocol amendments including primary endpoint modifications and enrollment target updates
Site expansions when new locations get added or enrollment scales up
New sponsor entrants when a company files its first trial in a disease area

Every change gets a severity label. A trial opening recruitment is critical. A site count going from 18 to 23 is notable. You decide what matters to you.

How it works

Build a watchlist

Pick the sponsors and diseases you care about. Track Pfizer in NSCLC, AstraZeneca in breast cancer, or any combination you want.

Get email digests

When something changes, you get an email. Pick daily or weekly. Only sends when there's actual news.

Landscape reports

See every sponsor in a disease area, grouped by trial phase. Spot who's expanding, who's stalling, who just showed up.

Pipeline Pulse

86 disease areas ranked by how much trial activity is happening right now. Find out where pharma is concentrating.

Who uses this

Biotech BD managers who need to know what competitors are doing in the clinic
Clinical ops teams tracking status changes across their own portfolio
Pharma analysts who need competitive intelligence but don't have a $20K budget for it
Investors and consultants following therapeutic area trends

What it costs

The free plan is free forever. You get one sponsor and one disease on your watchlist, daily change detection, and full access to search all 46,000+ trials. No credit card. No expiry.

If you need more watchlists and full landscape reports, Starter is $29/month. Pro is $99/month with unlimited watchlists and CSV export.

For comparison: Enterprise clinical trial intelligence platforms like Citeline Trialtrove and GlobalData typically require annual contracts with per-seat pricing that runs into tens of thousands of dollars per year.

Try it now

Sign up takes 30 seconds. Pick a sponsor and a disease and you'll have your first watchlist running before your coffee gets cold.

Get Started Free

83 New Sponsor Entrants This Week